SV Life Sciences raising sixth fund, goal is $400 million

SV Life SciencesWith nearly $2 billion under management, SV Life Sciences has started raising its sixth fund with a target of $400 million. The group invests in biotechnology, medical devices, health IT, and healthcare services. Click here for more information on the latest effort.

Tom Ballard

By Tom Ballard, Chief Alliance Officer,
Pershing Yoakley & Associates. P.C.

eNews & Updates

Sign up to receive posts via email.

Connect With Us

Upcoming Events

Links to Partners